Ferro, C. J., Haynes, W. G., Johnston, N. R., Lomax, C. C., Newby, D. E., & Webb, D. J. (1997). The peptide endothelin receptor antagonist, TAK-044, produces sustained inhibition of endothelin-1 mediated arteriolar vasoconstriction.

Ferro, C. J., W. G. Haynes, N. R. Johnston, C. C. Lomax, D. E. Newby, and D. J. Webb. The Peptide Endothelin Receptor Antagonist, TAK-044, Produces Sustained Inhibition of Endothelin-1 Mediated Arteriolar Vasoconstriction. 1997.

Ferro, C. J., et al. The Peptide Endothelin Receptor Antagonist, TAK-044, Produces Sustained Inhibition of Endothelin-1 Mediated Arteriolar Vasoconstriction. 1997.